Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Advertising & Marketing

Sales

Legal & Regulatory

Acquisition & Integration

Goodwill impairment

Restructuring costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Teladoc

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company was founded on June 13, 2002, by George Byron Brooks and Gary Wald and is headquartered in Purchase, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Teladoc reports solid Q4 growth, eyes revenue optimization strategies

Teladoc's Q4 performance showed revenue growth and margin focus, with BetterHelp contributing significantly to profitability.
The company's strategic focus on virtual care expansion and revenue optimization positions Teladoc for continued success in the healthcare market.
While facing internal restructuring challenges, Teladoc's emphasis on growth drivers and operational efficiency presents opportunities for future growth and market leadership.

Teladoc Health excels in Q1, eyes growth and efficiency

Teladoc Health's Q1 performance was strong, with revenue exceeding expectations.
The company is focused on efficiency, innovation, and driving value in virtual care.
BetterHelp segment showed growth and stability, with improving margins expected.
Opportunities exist to capitalize on ad pricing stability and consumer behavior trends.

Teladoc surpasses revenue expectations, focuses on innovation and growth

Teladoc's Q2 performance exceeded expectations, with strong revenue growth and improved margins in both segments. The company's strategic focus on whole-person care, weight management, and AI enhancements positions it well for future growth. Challenges include managing drug costs and private company valuations, while opportunities lie in virtual care demand and strategic M&A.
Teladoc's financial strength, commitment to innovation, and focus on efficiency improvements are key strengths driving its performance. The company's ability to navigate challenges and capitalize on opportunities in the evolving healthcare landscape underscores its resilience and growth potential.

Teladoc Health surpasses Q3 expectations, eyes margin expansion in '24

Teladoc Health's Q3 performance exceeded expectations, driven by revenue growth and margin improvements.
The company is focused on enhancing cost efficiencies, profitability, and driving margin expansion.
Stable pricing environment and strong client demand present opportunities for future growth.
Operational review and strategic initiatives position Teladoc for continued success in the healthcare sector.

Teladoc reports robust 2023 earnings, eyes growth amid marketing challenges

Teladoc delivered strong financial performance in 2023 with notable growth in adjusted EBITDA and revenue. The company faces challenges in BetterHelp marketing yields and delayed consumer engagement efforts.
However, Teladoc's strategic strengths lie in its long-term outlook for revenue growth, margin expansion, and cost-saving initiatives. Opportunities exist in optimizing sales force structure and capital deployment for future growth.
Overall, Teladoc's focus on profitability, growth optimization, and strategic capital allocation positions it well for sustained success in the telehealth industry.

Teladoc Health reports solid Q1 performance amidst revenue challenges

Teladoc Health's Q1 2024 performance showcased revenue growth in Integrated Care but challenges in BetterHelp segment revenue and margin management.
The company's financial strength, product portfolio, and cost initiatives position it well for growth opportunities and strategic market positioning.
Addressing challenges in ad spend management and focusing on international market efficiency are key to unlocking growth potential and improving financial performance.
Overall, Teladoc's performance, strengths, challenges, and opportunities reflect a dynamic landscape with strategic focus on sustainable growth and operational efficiency.

Teladoc Health reports Q2 revenue dip, EBITDA growth; addresses challenges

Teladoc Health's Q2 2024 performance showed mixed results with revenue decline but EBITDA growth. The company is leveraging strengths in patient safety and technology while addressing challenges in customer acquisition costs. Opportunities lie in operational efficiency, insurance coverage access, and international expansion.

Teladoc Health reports Q3 revenue decline but strategic growth

Teladoc Health's Q3 2024 performance reflects mixed results with revenue decline but strategic growth in the Integrated Care segment.
The company's focus on customer-centric strategies, technology, and clinical excellence positions it well for future success and market leadership.
Challenges in revenue decline and expense management require Teladoc Health to balance short-term financial performance with long-term growth objectives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002, by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in Purchase, NY.

Baidu

Datadog

Fiverr

Upstart Holdings

Investors endured a challenging 2022, with the Nasdaq Composite bringing up the caboose among the major U.S. indexes. No matter what Wall Street throws investors' way, being optimistic over the long run has been a recipe for success.

Nasdaq Bear Market: 5 Tremendous Growth Stocks You'll Regret Not Buying on the Dip

CVS Health

Global X Telemedicine & Digital Health ETF

In a world where uncertainty looms large in the financial markets, healthcare offers an incredible safe haven for investors. Telemedicine stocks, in particular, are not only a shelter but a gateway to the future of healthcare.

3 Telemedicine Stocks to Watch as Healthcare Goes Digital

Teladoc Health, Inc. (TDOC) Q1 2023 Earnings Call Transcript.

Teladoc Health, Inc. (TDOC) Q1 2023 Earnings Call Transcript

Teladoc (NYSE:TDOC) shares should bounce following a solid 1Q beat, according to analysts at Canaccord. During the quarter ended March 31, 2023, Teladoc (NYSE:TDOC) reported total revenue of $629.2 million, which beat both Canaccord estimates of $618.2 million.

Teladoc Health shares should bounce back following "solid" 1Q earnings beat: Canaccord

Teladoc outpaced analysts' average estimates in the quarter. The company's management is optimistic about the coming year.

Why Teladoc Stock Popped Today

After a horrible 2022, management owes investors a better year.

Teladoc Earnings: The Good and The Bad

While the top- and bottom-line numbers for Teladoc (TDOC) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Teladoc (TDOC) Reports Q1 Earnings: What Key Metrics Have to Say

Teladoc Health Inc. shares were up about 5% in after-hours trading Wednesday after the telemedicine company topped expectations with its first-quarter results and delivered an outlook that was better than anticipated at its midpoint.

Teladoc says it has ‘solid momentum' as revenue tops expectations

PURCHASE, NY, April 26, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the first quarter ended March 31, 2023.

Teladoc Health Reports First Quarter 2023 Results

Management has clearly laid out its strategy, and is executing on it. The company is delivering value to customers.

Can Teladoc Make Its Business Model Work?

Investing in these growth stocks could be a lucrative decision.

Best Growth Stock to Buy: Fiverr vs. Teladoc

Teladoc Health's (TDOC) first-quarter results are likely to reflect growth in Access Fees revenues and total visits.

Can Rising Expenses Hurt Teladoc Health's (TDOC) Q1 Earnings?

Inmode Ltd

Vertex Pharmaceuticals

Vertex Pharmaceuticals is a leader in its field, bringing in billions of dollars in annual earnings. Teladoc Health has steadily grown revenue, and telemedicine visits, by at least double-digit percentages.

3 Healthcare Stocks That Could Help Make You a Fortune

Teladoc Health stock recently shot up in response to its expansion of provider-based weight-management services. As the first virtual care platform to provide whole-person healthcare services, Teladoc Health has an advantage over smaller competitors.

Is Teladoc Health a Good Stock to Buy Now?

Teladoc (TDOC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Strength Seen in Teladoc (TDOC): Can Its 5.7% Jump Turn into More Strength?

Teladoc Is Just Getting Started

Teladoc Is Cheap At Current Valuation

Once a public market darling during the worst of the Covid-19 pandemic, Teladoc (NYSE: TDOC ) recently benefitted from a surge of relevance. Management announced that it intends to expand its telehealth services to weight management and prediabetes programs.

Why Is Teladoc (TDOC) Stock Up 6% Today?

Sibanye Stillwater

Markets were mostly flat near midday on Tuesday. Teladoc Health announced a new initiative to help those suffering from obesity or pre-diabetes.

These 2 Mid-Cap Stocks Jumped More Than 10% Tuesday

Teladoc Health now offers provider-based care for its weight management and pre-diabetes programs. This includes a personalized care plan from a Teladoc physician combined with the company's digital tools, helping to manage these chronic health conditions.

Why Teladoc Health Stock Rocketed Higher Tuesday Morning

Teladoc (NYSE: TDOC) stock price has bounced back recently as investors anticipate a potential pivot of the Federal Reserve. The shares jumped by more than 10% on Tuesday as it reached the highest point since February.

Teladoc stock: cautiously optimistic even as insiders dump shares

Teladoc (NYSE:TDOC) said it is adding weight management and prediabetes programs, including the prescription of weight loss medications, to its Provider-Based Care programs, sending its share price higher. The virtual care provider's shares had added 11.5% at US$28.84 on Tuesday morning.

Teladoc shares rise on launch of weight management and prediabetes programs

Ongoing physician support ensures highest clinical quality as new therapies gain popularity Ongoing physician support ensures highest clinical quality as new therapies gain popularity

Teladoc Health Launches Provider-Based Care for Weight Management & Prediabetes Programs

Aurora Cannabis

Novavax

Thanks to 13F filings, investors can follow what the brightest minds on Wall Street have been buying and selling. In spite of their poor performance, three beaten-down stocks were aggressively purchased by billionaire investors during the fourth quarter.

3 Former High-Flying Stocks Down 92% to 99% That Billionaire Investors Can't Stop Buying

Teladoc Health (TDOC) remains well-poised for growth on the back of solid revenues, sustained demand for virtual care services and sufficient cash-generating abilities.

News for Teladoc Stock (TDOC)